China's CR gets TCM firm
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
China Resources Pharmaceutical has acquired a controlling stake in traditional Chinese medicines (TCMs) manufacturer Jiangzhong Group for an undisclosed sum.